This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Abstract Background/Aims: Tempol is a protective antioxidant against ischemic injury in many animal models. The molecular mechanisms are not well understood. Nuclear factor erythroid 2-related factor (Nrf2) is a master transcription factor during oxidative stress, which is enhanced by activation of protein kinase C (PKC) pathway. Another factor, tubular epithelial apoptosis, is mediated by activation of phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB, Akt) signaling pathway during renal ischemic injury. We tested the hypothesis that tempol activates PKC or PI3K/Akt/Nrf2 pathways to transcribe many genes that coordinate endogenous antioxidant defense. Methods: The right renal pedicle was clamped for 45 minutes and the left kidney was removed to study renal ischemia/reperfusion (I/R) injury in C57BL/6 mice. The response was assessed from serum parameters, renal morphology and renal expression of PKC, phosphorylated-PKC (p-PKC), Nrf2, heme oxygenase-1 (HO-1) , Akt, phosphorylated-Akt (p-Akt), pro-caspase-3 and cleaved caspase-3 in groups of sham and I/R mice given vehicle, or tempol (50 or 100 mg/kg, intraperitoneal injection). Results: The serum malondialdehyde (MDA, marker of reactive oxygen species) doubled and the BUN and creatinine increased 5-to 10-fold after I/R injury. Tempol (50 or 100 mg/kg) prevented the increases in MDA but only tempol (50 mg/kg) lessened the increases in BUN and creatinine and moderated the acute tubular necrosis. I/R did not change expression of PKC or p-PKC but reduced renal expression of Nrf2, p-Akt, HO-1 and pro-caspase-3 and increased cleaved caspase-3. Tempol (50 mg/kg) prevented these changes produced by I/R whereas tempol (100 mg/kg) had lesser or inconsistent effects. Conclusion: Tempol (50 mg/kg) prevents lipid
Introduction
Acute kidney injury (AKI) is a common and catastrophic complication in hospitalized patients [1, 2] . Although AKI has been studied extensively, the intracellular signaling pathways that are involved in AKI remain unclear [3] .
Renal ischemia/reperfusion (I/R) injury is a common cause of AKI. It initiates a complex and interrelated sequence of events within the kidney that culminate in renal injury and death of renal cells [4] . Endothelial dysfunction and tubular cell injury through ATP depletion, accumulation of intracellular Ca
2+
, reactive oxygen species (ROS) and proinflammatory cytokines, and apoptotic pathway have all been implicated [5, 6] . Of these, the excessive generation of ROS causes damage and death of renal tubular epithelial cells [7] . The role of ROS in the pathophysiology of I/R injury is supported by increased formation of lipid peroxidation and other toxic products following renal injury [8, 9] .
Nuclear factor erythroid 2-related factor (Nrf2) is a master regulator of antioxidant defense gene [10] and a master transcription factor released during oxidative stress [11] . The accumulated Nrf2 in the nucleus binds to antioxidant response elements (ARE) on the genes for phase 2 enzyme that upregulate many proteins involved in the metabolism of ROS during I/R injury [12] [13] [14] . Therefore, we hypothesize that upregulation of Nrf2 signaling may reduce renal damage and enhance repair after I/R injury.
Activation of the protein kinase C (PKC) pathway enhances Nrf2 expression and can protect kidney against I/R damage [15, 16] . However, tubular epithelial apoptosis is another factor that is induced by renal I/R injury and could account for acute tubular necrosis. Indeed, the phosphoinositide 3-kinase/Akt (PI3K/Akt) pathway can mediate cell survival in many cell types [17] , including renal cells [18] . This pathway was originally recognized to play a critical role in regulating cell growth and survival [19] and more recently has been implicated in the protection of liver and kidney against I/R injury by moderating the inflammatory response [20, 21] . This may involve in activation of Nrf-2 but its specific role is not established. Renal cell injury culminates in regeneration and repair, or in renal cell apoptosis.
The redox-cycling antioxidant tempol has been much studied. It can act both as a superoxide dismutase (SOD) and as a catalase member [22] [23] . All of these were almost restored to levels of sham operated mice by tempol administration. Tempol can protect the kidneys against acute inflammation by restoring hypoxia inducible factor-1α (HIF-1a) expression, increasing renal parenchymal PO 2 and down-regulating transforming growth factor β1 (TGF-β1) expression [24] . Unbalance among oxygen, NO, and ROS is an important component of the pathogenesis of I/R-induced AKI. Indeed, tempol can improve tissue NO and PO 2 , reduce TGFβ and the associated inflammation and protect the kidney from I/R-induced injury [25] [26] [27] [28] . However, the mechanism has not been well elucidated. Thus, the aim of the present investigation is to investigate the protective role of tempol in renal I/R injury and its interaction with the PKC and/or PI3K/Akt pathways. peroxidation and attenuates renal damage after I/R injury. The beneficial pathway apparently is not dependent on upregulation or phosphorylation of PKC, at lower tempol doses, does implicate upregulation of Akt with expression of Nrf2 that could account for the increase in the antioxidant gene HO-1 and a reduction in the cleavage of the cellular damage marker pro-caspase-3.
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Materials and Methods

Reagents
Unless otherwise stated, all reagents were obtained from Sigma-Aldrich (St Louis, MO, USA).
Experimental Animals and Protocols
Male C57BL/6 mice weighing 24-28 g (12 weeks old) were obtained from Zhejiang Medical Animal Centre (Hangzhou, China). Mice were housed under climate-controlled conditions with a 12-h light/ dark cycle and provided with standard food and water. All experimental protocols and animal handling procedures were performed in accordance with the National Institutes of Health (NIH, USA) guidelines for the care and use of laboratory animals and were approved by the Committees for Animal Experiments at Zhejiang University in China. Tempol (50 or 100 mg/kg, intraperitoneal injection) was administered at 60 minutes prior to the renal I/R injury [29, 30] .
Kidney ischemia/reperfusion model Mice were randomly divided into four groups: (1) sham; (2) I/R group (vehicle group); (3) I/R + tempol (50 mg/kg) group; and (4) I/R + tempol (100 mg/kg) group. To induce I/R model, mice were anesthetized with 3% chloral hydrate. The right renal pedicle clamped for 45 minutes and left nephrectomy performed to produce severe renal injury. Thereafter, the clamp was released to allow reperfusion. Sham-operated mice were dissected as above, but with no occlusion of the renal pedicle. The rectal temperature was monitored throughout and maintained at 37 ± 0.5°C with a heating blanket. All mice were sacrificed by decapitation at 24 h after reperfusion, and the kidneys were dissected and collected for further analysis.
Determination of serum creatinine, BUN and MDA
Before euthanatized, blood was sampled from the inferior vena cava and centrifuged at 3000 rpm, 4°C for 15 min. Serum creatinine and BUN were measured by an automatic biochemical analyzer. Serum Malondialdehyde (MDA) concentration was measured by a Kit (Lipid Peroxidation MDA Assay Kit, Beyotime Biotechnology, China).
Morphology
Renal tissue fixed in 4% paraformaldehyde was processed by dehydration and embedded in paraffin. Sections were cut at 4 µm intervals and stained with Hematoxylin-Eosin (H&E) for histological assessment by a designated pathologist blinded to the experimental groups.
Immunoblotting analysis
After euthanatized, the kidneys were dissected and stored at -80°C. Frozen kidney tissue samples were homogenized in buffer containing 50 mM Tris-HCl (pH 7.4), 0.5% Triton X-100, 4 mM EGTA, 10 mM EDTA, 1 mM Na3VO4, 30 mM sodium pyrophosphate, 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 50 μg/ mL leupeptin, 30 μg/mL aprotinin and 1 mM dithiothreitol (DTT). The homogenate was centrifuged 5 min at 10,000 g at 4°C. The insoluble pelleted nuclei were resuspended in ice-cold buffer; and nuclear protein fractions were prepared as described previously [31] .
Cell lysates or nuclear extracts from kidney tissue containing equivalent amounts of protein were analyzed by 10-13.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) as described previously [32] [33] [34] . Proteins were transferred to an immobilon polyvinylidene difluoride membrane for 1h at 50 V. Membranes were blocked in 20 mM Tris-HCl (PH 7.4), 150 mM NaCl, and 0.1% Tween 20 (TBS-T) containing 5% fat-free milk powder for 1 h and immunodetected with antibodies to Nrf2 
Statistical analysis
The significance of the differences between the different groups was determined using a one-way ANOVA and considered to be significant at P < 0.05. All data are expressed as the mean ± SD.
Results
Effects of tempol on renal function after I/R injury
The serum BUN and creatinine increased 5-to 10-folds in mice after renal I/R injury (vehicle group) and were significantly, but modestly, reduced by tempol (50 mg/kg), but not by tempol (100 mg/kg) ( Table 1) . 
Effect of tempol on lipid peroxidation after I/R injury
Schematic illustration of the potential mechanisms of tempol on I/R injury induced oxidative stress and apoptotic signaling
These data suggest that I/R injury increases ROS that down-regulate the expression of Akt and Nrf2, thereby reducing its antioxidant responses, promoting activation of caspase-3 and culminating in renal cell death and dysfunction. Pharmacological inhibition of ROS formation by tempol, especially at the lower dose, reduced or prevented these effects.
Discussion
AKI causes a high mortality [38] . Its primary causes are renal ischemia, hypoxia or nephrotoxicity [39, 40] . I/R injury increases renal ROS and decreases endogenous antioxidants [41] . I/R injury occurs in many clinical circumstances in which kidney damage can be some causes of renal transplantation, shock, and vascular surgery and administration of radiology contrast agents. However, therapeutic modalities that prevent acute kidney injury are still extremely limited. The pathophysiological mechanism of I/R injury includes endothelial dysfunction, generation of ROS and pro-inflammatory cytokines and activation of apoptotic pathways [42] . Signal pathways activated by I/R injury include PKC, Nrf2, PI3K/ Akt, inflammation and apoptosis [43] [44] [45] [46] .
Our results confirm reports that tempol protects the kidney from ischemic damage [25] [26] [27] [28] , but shows a complex and dose-dependent mechanism. Although there were some inconsistent results between the doses of tempol used, the current study demonstrated the following findings: (1) I/R renal injury increases lipid peroxidation (a marker of ROS). (2) Both doses of tempol reduced the morphologic renal damage and corrected the activation of the apoptotic pathway (from the expression of caspase and pro-caspase). (3) The lower dose of tempol restored Nrf2 activation (from nuclear expression), downstream signaling (from to ischemia-reperfusion and chemotherapy-induced nephrotoxicity. Tempol can directly metabolize ROS, including both superoxide and hydrogen peroxide. However, tempol has also been shown to reset the endogenous anti-oxidant defense system so as to provide additional, and more prolonged, anti-oxidant effect [22, 28] . This study demonstrates that one important mechanism of cellular defense after tempol involves upregulation of Nrf2 and its downstream genes, including HO-1. However, this pathway was only activated after lower dose of tempol. On the other hand, low and high doses of tempol prevented lipid peroxida- HO-1 expression) and upstream activation (from p-Akt expression), but paradoxically the high dose of tempol was not effective. The PKC, p-PKC was not activated by I/R injury, nor was the cytoplasmic Nrf2 expression altered.
Oxidative stress is involved in acute kidney injury due Zhang/Wang/Zhou/Wang/Xu/Wang/Wang/Wilcox/Liu/Lai: Protective Effect of Tempol on Acute Kidney Injury tion, activated Akt, and prevented cellular apoptosis and renal damage. This suggests that there may be multiple, dose-dependent effects of tempol to alleviate oxidative stress and its consequences in the kidney that may underline some previous inconsistent reports in the literatures [25] . The data suggested that the renal injury induced by ischemia/reperfusion was related to oxidative stress and that tempol restored the expression of Nrf2-dependent cytoprotective pathways and that blocked ischemia/reperfusion-induced apoptosis.
Conclusion
Our findings using the ischemia model demonstrated that tempol effectively prevented against I/R-induced renal injury through PI3K/Akt/Nrf2 and caspase-3, not PKC/Nrf2 signaling pathway.
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